Enthusiastic team leader with unique experience in research, CMC (conception through commercialization of biologics) and regulatory matters aiming at improving patients' lives.
Overview
27
27
years of professional experience
Work History
Research Assistant
University of Maryland Baltimore County
Lab scientist who explored novel yeast cell growth media to improve cell wall integrity, allowing for greater agitation and oxygenation during fermentation, and ultimately improving protein expression
Associate Director
AstraZeneca
03.2020 - Current
CMC Project Lead for an early stage asset, pioneering technical and business processes (continuous processing end-to-end for clinical production), leveraging external and internal CMC focused working groups
Scientist II
AstraZeneca (Medimmune)
06.2017 - 03.2020
Downstream CMC representative for Saphnelo and Adbry/Adtralza through process characterization, validation, global regulatory submissions and responses
Scientist I
AstraZeneca (Medimmune)
03.2014 - 06.2017
Lead scientist in the development a scale-down model for process intermediate hold time characterization, which replicates storage conditions at the manufacturing site, and developed a template protocol for the execution of characterization studies
Research Scientist II
NCI-Frederick
06.2008 - 03.2014
Lead researcher in the development and optimization of protein purification methods enabling the identification and validation of protein-protein and protein-DNA interactions
Post-doctoral Research Fellow
NCI-Frederick
03.2007 - 06.2008
Project lead exploring changes in human plasma protein levels of HIV patients over the course of disease progression by using HPLC to deplete abundant proteins and Time-of-Flight Mass Spectrometry to quantify proteins of interest
Graduate Student / Post-Doc
Johns Hopkins University
09.2001 - 02.2007
Graduate student lead for a project using recombinant DNA technology for the construction of protein libraries
Developed assays for the selection of proteins with desired properties
Manufacturing Engineer
Perkin Elmer Fluid Sciences
12.2000 - 08.2001
Design engineer for tooling used to manufacture custom ordered metallic seals
Engineering Intern
Perkin Elmer Fluid Sciences
02.1997 - 12.2000
One of only two interns supporting the entire Metallic Seal Business unit in seal and tooling design, as well as metal plating
Education
Doctor of Philosophy - Chemical and Biomolecular Engineering
Johns Hopkins University
Baltimore, MD
09.2006
Bachelor of Science - Chemical Engineering
University of Maryland Baltimore County
Baltimore, MD
12.2000
Skills
Expert in cross functional CMC matters (from early process development though validation and commercialization), with deeper knowledge on purification, technology transfer, and regulatory submission delivery
Experienced matrix manager of large high performing teams delivering innovative solutions
Exceptional communicator (demonstrated through project lead experience, contributions to global regulatory submissions, and publications)
Effective strategist, driving improved efficiency through solid analytical reasoning
Publications
Process Development and Characterization for Integrated Continuous Bioprocesses – Highlights from N-mAb, K. Brower, K. Wiltberger, C. Berdugo, A Bosley, E. Goodrich, V. Pferdeort, G. Shaefer, Biotechnology Progress, 2024
Managing Integrated Continuous Bioprocess in Real Time: Deviations in Product Quality, G. Grampp, A. Bosley, M. Qadan, J. Schiel, A. Spasoff, P. Valax, G. Shaefer, Biotechnology Progress, 2023
Improved Process Intermediate Stability Through the Identification and Elimination of reactive Glycation Residues- A Monoclonal Antibody Case study., A. Bosley, K. Cook, S. Lin, D. Robbins, Bioengineered, 2022
N-mAb A Case Study to Support Development and Adoption of the Integrated Continuous Bioprocesses for Monoclonal Antibodies., 55 authors representing 22 organizations (Industry, government, and academia), National Institute for Innovation in Manufacturing Biopharmaceuticals, 2022
Kinetic Modeling as a Tool to Understand the Influence of Cell Culture Process Parameters on the Glycation of Monoclonal Antibody Biotherapeutics, N. Agarwal, A. Mason, R. Pradhan, J. Kemper, A. Bosley, D. Serfiotis-Mitsa, J. Wang, V. Lindo, S. Ahuja, D. Hatton, J. Savery, G. Miro-Quesada, Biotechnology Progress, 2019
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells., J. Jia, A.D. Bosley, A. Thompson, J. Hoskins, A. Cheuk, I. Collins, H. Parikh, Z. Xiao, K. Ylaya, M. Dzyadyk, W. Cozen, B. Hernandez, C. Lynch, S.F. Altekruse, L. Zhang, C.J. Westlake, V.M. Factor, S.Thorgeirsson, W.Bamlet, S.M. Hewitt, J. Khan, G. Petersen, T. Andresson, L.T. Amundadottir, Cancer Research, 2014
SIRT3 Deacetylates ATP Synthase F1 Complex Proteins in Response to Nutrient and Exercise-Induced Stress., A. Vassilopoulos, J.D. Pennington, T. Andresson, D. Rees, A.D. Bosley, I.M. Fearnley, A. Ham, C.R. Flynn, S. Hill, K.L. Rose, H. Kim, C. Deng, J. Walker, D. Gius, Antioxidants and Redox Signaling, 2013
BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane., J. Alsarraj, F. Faraji, T.R. Geiger, K.R. Mattaini, M. Williams, J. Wu, N.Ha, T. Merlino, R.C. Walker, A.D. Bosley, Z. Xiao, T. Andresson, D. Esposito, N. Smithers, D. Lugo, R. Prinjha, A. Day, N.P.S. Crawford, K. Ozato, K. Gardner, K.W. Hunter, PLOS ONE, 2013
A Role for Protein–Protein Interaction Networks in the Identification and Characterization of Potential Biomarkers., A.D. Bosley, S. Das, T. Andresson, Proteomic and Metabolomic Approaches to Biomarker Discovery (Book Chapter), 2013
The UBIAD1 prenyltransferase links menaquinone-4 synthesis to cholesterol metabolic enzymes., M.L. Nickerson, A.D. Bosley, J.S. Weiss, B.N. Kostiha, Y. Hirota, W. Brandt, D. Esposito, S. Kinoshita, L. Wessjohann, S.G. Morham, T. Andresson, H.S. Kruth, T. Okano, M. Dean, Human Mutatation, 2013
Comparison of strong cation exchange and SDS-PAGE fractionation for analysis of multiprotein complexes., S. Das, A.D. Bosley, Ye X, K.C. Chan, I Chu, J.E. Green, H.J. Issaq, T.D. Veenstra, T. Andresson, J Proteome Res., 2010
A method of HIV-1 inactivation compatible with antibody based depletion of abundant proteins from plasma, A. Bosley, H. N. Marshall, Y. Badralmaa, V. Natarajan, Proteomics-Clinical Application, 2008
A bacterial one-hybrid system for interrogating Zinc Finger-DNA interactions., S. Durai, A. D. Bosley, A.B. Abulencia, S. Chandrasegaran, M. Ostermeier, Combinatorial Chemistry and High Throughput Screening, 2006
Mathematical expressions useful in the construction, description and evaluation of protein libraries., A. Bosley, M. Ostermeier, Biomolecular Engineering, 2005
Timeline
Associate Director
AstraZeneca
03.2020 - Current
Scientist II
AstraZeneca (Medimmune)
06.2017 - 03.2020
Scientist I
AstraZeneca (Medimmune)
03.2014 - 06.2017
Research Scientist II
NCI-Frederick
06.2008 - 03.2014
Post-doctoral Research Fellow
NCI-Frederick
03.2007 - 06.2008
Graduate Student / Post-Doc
Johns Hopkins University
09.2001 - 02.2007
Manufacturing Engineer
Perkin Elmer Fluid Sciences
12.2000 - 08.2001
Engineering Intern
Perkin Elmer Fluid Sciences
02.1997 - 12.2000
Research Assistant
University of Maryland Baltimore County
Doctor of Philosophy - Chemical and Biomolecular Engineering
Retriever Essentials Greeter at University of Maryland, Baltimore County, UMBCRetriever Essentials Greeter at University of Maryland, Baltimore County, UMBC
Research Assistant - Food Quality Monitoring at University of Maryland, Baltimore CountyResearch Assistant - Food Quality Monitoring at University of Maryland, Baltimore County
Certified Salesforce System Administrator at University of Maryland Baltimore CountyCertified Salesforce System Administrator at University of Maryland Baltimore County